N4 Pharma (LON:N4P) Stock Price Up 23.8% – What’s Next?

Shares of N4 Pharma Plc (LON:N4P) rose 23.8% during trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 10,628,002 shares were traded during mid-day trading, an increase of 331% from the average daily volume of 2,466,094 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Performance

The firm has a market cap of £2.39 million, a PE ratio of -55.00 and a beta of -0.37. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The firm’s 50 day simple moving average is GBX 0.62 and its 200 day simple moving average is GBX 0.57.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.